Donald Trump’s proposed 200 per cent tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
Donald Trump’s proposed 200 per cent tariff on generic drug imports is less a blow to India’s pharmaceutical industry than a costly gamble that could leave American patients paying the highest price.
[T]he fraternal interaction among fans from dozens of countries and the local public reminded us that isolationism is not the dominant sentiment among 349 million Americans.
The era of political multipolarity has arrived, and a security framework based on unilateral dependence is only becoming more inadequate against complex threats.